Scarica l'app Stockscreener
6.58
0.30%
0.02
Precedente Chiudi:
$6.56
Aprire:
$6.19
Volume 24 ore:
972.23K
Relative Volume:
0.69
Capitalizzazione di mercato:
$688.48M
Reddito:
$69.65M
Utile/perdita netta:
$-81.27M
Rapporto P/E:
-7.2403
EPS:
-0.9088
Flusso di cassa netto:
$-79.45M
1 W Prestazione:
-10.11%
1M Prestazione:
-27.37%
6M Prestazione:
-2.81%
1 anno Prestazione:
+84.83%
Intervallo 1D:
$6.15
$6.785
Intervallo di 1 settimana:
$6.04
$7.32
Portata 52W:
$2.8262
$11.50
Personalis Inc Stock (PSNL) Company Profile
Nome
Personalis Inc
Settore
Industria
Telefono
650-752-1300
Indirizzo
6600 DUMBARTON CIRCLE, FREMONT, CA
Compare PSNL vs TMO, DHR, IDXX, A, WAT
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PSNL
Personalis Inc
|
6.58 | 688.48M | 69.65M | -81.27M | -79.45M | -0.9088 |
TMO
Thermo Fisher Scientific Inc
|
491.46 | 182.57B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
191.12 | 135.26B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
569.55 | 45.24B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
115.48 | 32.63B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
304.24 | 29.85B | 3.17B | 642.63M | 516.49M | 10.77 |
Personalis Inc Stock (PSNL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-02 | Ripresa | Morgan Stanley | Equal-Weight |
| 2025-05-15 | Iniziato | Guggenheim | Buy |
| 2025-03-17 | Iniziato | Craig Hallum | Buy |
| 2023-02-06 | Aggiornamento | Needham | Hold → Buy |
| 2022-01-07 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2021-11-05 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-03 | Downgrade | Needham | Buy → Hold |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-09-20 | Reiterato | Needham | Buy |
| 2021-05-06 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2021-01-28 | Iniziato | Truist | Buy |
| 2021-01-04 | Downgrade | BofA Securities | Buy → Neutral |
| 2020-11-12 | Reiterato | Needham | Buy |
| 2020-11-06 | Downgrade | Oppenheimer | Outperform → Perform |
| 2020-10-19 | Iniziato | Citigroup | Buy |
| 2020-10-08 | Iniziato | BTIG Research | Buy |
| 2020-08-27 | Iniziato | H.C. Wainwright | Buy |
| 2020-08-18 | Iniziato | Needham | Buy |
| 2019-09-26 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-07-15 | Iniziato | BofA/Merrill | Neutral |
| 2019-07-15 | Iniziato | Cowen | Outperform |
| 2019-07-15 | Iniziato | Morgan Stanley | Overweight |
| 2019-07-15 | Iniziato | Oppenheimer | Outperform |
Mostra tutto
Personalis Inc Borsa (PSNL) Ultime notizie
Executive pay, board elections headline Personalis (PSNL) 2026 proxy - Stock Titan
Personalis, Inc. (PSNL) stock price, news, quote and history - Yahoo Finance Singapore
Personalis to Participate in the 25th Annual Needham Virtual Conference - barchart.com
Operating cash flow per share of Personalis, Inc. – DUS:04X - TradingView
Personalis Surges 12% Pre-Market with No Clear Catalyst - Bitget
Morgan Stanley lowers Personalis (PSNL) price target to $10 - MSN
Dow Update: Is Personalis Inc benefiting from interest rate changesMarket Volume Report & Free Weekly Watchlist of Top Performers - baoquankhu1.vn
Personalis (NASDAQ:PSNL) Trading Down 9.3%Should You Sell? - MarketBeat
Personalis stock rises after Medicare approves lung cancer test coverage - Investing.com
Sell Signal: Can Personalis Inc deliver consistent EPS growthOil Prices & Weekly Setup with High ROI Potential - baoquankhu1.vn
Morgan Stanley Lowers Personalis (PSNL) Price Target to $10 - Insider Monkey
10 best diagnostics and research stocks to buy according to analysts - msn.com
Should you avoid Personalis Inc stock right now2026 Trade Ideas & Weekly Breakout Opportunity Watchlist - baoquankhu1.vn
PSNL SEC FilingsPersonalis 10-K, 10-Q, 8-K Forms - Stock Titan
Personalis, Inc. (PSNL): A bull case theory - MSN
Personalis appoints Richard Chen as president and updates compensation package - au.investing.com
229,435 Shares in Personalis, Inc. $PSNL Bought by Oracle Investment Management Inc. - MarketBeat
Personalis Appoints Dr. Richard Chen as President to Further Accelerate MRD Adoption - BioSpace
Personalis promotes Richard Chen to president role By Investing.com - za.investing.com
Personalis appoints Richard Chen as president and updates compensation package By Investing.com - Investing.com India
Personalis (PSNL) Appoints Richard Chen as President - GuruFocus
Personalis (PSNL) CFO granted 206,250 options and 34,375 RSUs - Stock Titan
Personalis (PSNL) grants options and RSUs to Chief Legal Officer - Stock Titan
Personalis (PSNL) CEO receives major stock option and RSU grants - Stock Titan
Personalis (PSNL) awards RSUs and stock options to its CMO - Stock Titan
Investor Mood: Can Personalis Inc grow without external funding2026 Chart Watch & Expert Approved Trade Ideas - baoquankhu1.vn
Personalis promotes Richard Chen to president role - Investing.com
Personalis (NASDAQ: PSNL) elevates Richard Chen to President - Stock Titan
Aug Movers: Should you avoid Personalis Inc stock right now2026 Price Momentum & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn
Personalis Q2 2025 Earnings Preview - MSN
Personalis (NASDAQ:PSNL) Trading 6.6% HigherTime to Buy? - MarketBeat
Personalis (NASDAQ:PSNL) Stock Price Down 8.1%What's Next? - MarketBeat
Personalis Announces New Publication Advancing Neoadjuvant Treatment Monitoring in Breast Cancer with NeXT Personal - BioSpace
Personalis (PSNL) Publishes Promising Study on Cancer Detection Method - GuruFocus
Personalis Announces New Publication Advancing Neoadjuvant Treatment Monitoring in Breast Cancer with NeXT Personal® - Business Wire
Personalis, Inc. (NASDAQ:PSNL) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Growth Report: Is Personalis Inc showing insider buyingEarnings Growth Report & Consistent Profit Trade Alerts - baoquankhu1.vn
Personalis (PSNL) Surges 14.2%: Is This an Indication of Further Gains? - MSN
Personalis (NASDAQ:PSNL) Rating Increased to Hold at Wall Street Zen - MarketBeat
Momentum Shift: Is Personalis Inc benefiting from interest rate changesJuly 2025 Earnings & Short-Term Trading Opportunity Alerts - baoquankhu1.vn
Is Personalis Inc. stock attractive after correctionTrade Risk Summary & Weekly High Momentum Picks - Naître et grandir
Personalis Stock Pre-Market (-5.3%): FY26 Guidance Overshadows Q4 EPS Beat - Trefis
Morgan Stanley Has Lowered Expectations for Personalis (NASDAQ:PSNL) Stock Price - MarketBeat
PSNL: Morgan Stanley Maintains Equal-Weight, Lowers Price Target - GuruFocus
Personalis, Inc. $PSNL Stake Boosted by ARK Investment Management LLC - MarketBeat
Personalis, Inc. (NASDAQ:PSNL) Short Interest Up 21.2% in February - MarketBeat
Personalis (NASDAQ:PSNL) Shares Gap DownTime to Sell? - MarketBeat
Will Personalis Inc. outperform small cap indexesBear Alert & Free Verified High Yield Trade Plans - mfd.ru
Breaking Down Personalis: 5 Analysts Share Their Views - Sahm
Personalis Inc Azioni (PSNL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Personalis Inc Azioni (PSNL) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Tempus AI, Inc. | 10% Owner |
Nov 25 '25 |
Buy |
10.62 |
23,600 |
250,665 |
12,918,346 |
| Tempus AI, Inc. | 10% Owner |
Dec 22 '25 |
Buy |
8.93 |
28,000 |
250,040 |
13,039,067 |
| Tempus AI, Inc. | 10% Owner |
Nov 21 '25 |
Buy |
9.40 |
26,499 |
249,190 |
12,869,521 |
| Tempus AI, Inc. | 10% Owner |
Nov 24 '25 |
Buy |
9.87 |
25,225 |
248,971 |
12,894,746 |
| Tempus AI, Inc. | 10% Owner |
Nov 19 '25 |
Buy |
8.12 |
30,645 |
248,837 |
12,814,195 |
| Tempus AI, Inc. | 10% Owner |
Nov 20 '25 |
Buy |
8.63 |
28,827 |
248,777 |
12,843,022 |
| Tempus AI, Inc. | 10% Owner |
Dec 17 '25 |
Buy |
7.86 |
31,650 |
248,769 |
12,949,996 |
| Tempus AI, Inc. | 10% Owner |
Dec 19 '25 |
Buy |
8.39 |
29,641 |
248,688 |
13,011,067 |
| Tempus AI, Inc. | 10% Owner |
Dec 18 '25 |
Buy |
7.91 |
31,430 |
248,611 |
12,981,426 |
| Tachibana Aaron | CFO AND COO |
Jan 22 '26 |
Option Exercise |
9.16 |
1,201 |
11,001 |
165,659 |
0.17%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):